PMGC HOLDINGS INC. Loans Payable, Current
PMGC HOLDINGS INC. (ELAB) had Loans Payable, Current of $350.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2024-11-14
- 2024-09-30: Loans Payable, Current $350.00K.
- 2024-06-30: Loans Payable, Current $348.40K.
- 2024-03-31: Loans Payable, Current $338.89K.
| Period end | Loans Payable, Current |
|---|---|
| 2024-09-30 | $350.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $348.40K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $338.89K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |